<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="rss.xsl"?>
<rss version="2.0">
  <channel>
          <title>Pharmaceuticals - livepress.com</title>
      <link>http://Pharmaceuticals.livepress.com</link>
        <description>Updated every 15 minutes of every day - FOR PERSONAL USE ONLY</description>
    <language>en</language>
    <lastBuildDate/>
    <copyright>Copyright: (C) livepress.com</copyright>
    <docs/>
    <image>
      <title>livepress.com</title>
      <url>http://livepress.com/img/logo-live-press.gif</url>
      <link>http://livepress.com</link>
    </image>

    <item>
      <title><![CDATA[Hospira net falls as expenses jump 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?136205</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?136205</guid>
      <pubDate>2006-08-09 10:54:31</pubDate>
      	<description><![CDATA[Reuters - Hospira Inc. , which makes 
specialty  pharmaceuticals  and medication-delivery systems, on 
Wednesday said quarterly earnings fell 25 percent as sales were 
nearly flat and expenses surged.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136200.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Barr to refile contraceptive bid within 2 weeks 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?135544</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?135544</guid>
      <pubDate>2006-08-08 14:13:20</pubDate>
      	<description><![CDATA[    Reuters - Barr  Pharmaceuticals  Inc.  
aims to resubmit its application to sell its Plan B 
morning-after contraceptive pill within two weeks, the company 
said on Tuesday, following a meeting with U.S. Food and Drug 
Administration officials.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136168.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[FDA, Barr to discuss looser Plan B sales 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?130359</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?130359</guid>
      <pubDate>2006-07-31 12:19:13</pubDate>
      	<description><![CDATA[Reuters - The U.S. Food and Drug 
Administration and Barr  Pharmaceuticals  Inc.  will meet 
to discuss the possible approval of nonprescription sales of 
the Plan B "morning-after" contraceptive to women 18 and older, 
the agency said on Monday.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136158.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[FDA to talk with Barr on Plan B proposal 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?130351</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?130351</guid>
      <pubDate>2006-07-31 12:04:07</pubDate>
      	<description><![CDATA[Reuters - The U.S. Food and Drug 
Administration will meet with officials from Barr 
 Pharmaceuticals  Inc.  to discuss the possible approval 
of nonprescription sales of the Plan B "morning-after" 
contraceptive to women 18 and older, the agency said on Monday.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136142.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[FDA clears AstraZeneca asthma drug 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?124887</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?124887</guid>
      <pubDate>2006-07-22 08:54:47</pubDate>
      	<description><![CDATA[    Reuters - AstraZeneca Plc  has won U.S. 
approval for its asthma drug Symbicort, significantly earlier 
than most industry analysts had expected, a person familiar 
with the matter said on Saturday.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136204.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Barr enters bidding race to buy Pliva: report 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?97032</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?97032</guid>
      <pubDate>2006-05-29 08:54:26</pubDate>
      	<description><![CDATA[Reuters - U.S. drug maker Barr  Pharmaceuticals  
 has entered the bidding for Croatian pharmaceutical 
group Pliva (PLVxq.L), the Financial Times newspaper said on 
Monday.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136203.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Barr says Lilly sues to stop generic weekly Prozac 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?85269</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?85269</guid>
      <pubDate>2006-05-11 11:23:04</pubDate>
      	<description><![CDATA[Reuters - Barr  Pharmaceuticals  Inc.  on 
Thursday said  Eli Lilly  & Co.  has sued the company, 
claiming Barr's generic weekly form of anti-depressant Prozac 
infringes the patent on Lilly's branded medicine.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136191.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Animal Rights Activists Target Glaxo Investors]]></title>
      <link>http://livepress.com/go/?84676</link>
      <source>AHN</source>
      <guid isPermaLink="false">http://livepress.com/go/?84676</guid>
      <pubDate>2006-05-10 16:56:35</pubDate>
      	<description><![CDATA[ Europe's biggest  pharmaceuticals  manufacturer, GlaxoSmithKline, says shareholders were told they would have their details posted on the internet if they did not sell their shares within 14 days in a threatening letter by animal rights...]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136192.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Ariad's Shares Climb 40 Percent After It Wins Patent Case]]></title>
      <link>http://livepress.com/go/?82436</link>
      <source>AHN</source>
      <guid isPermaLink="false">http://livepress.com/go/?82436</guid>
      <pubDate>2006-05-05 03:04:29</pubDate>
      	<description><![CDATA[ Ariad  Pharmaceuticals  Inc. shares climbed up to 40 percent on Thursday after the company announced it won a patent infringement case against  Eli Lilly  and Co.
 Reuters reports a federal court in Massachusetts decided that Lilly's osteoporosis...]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136190.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Texas plaintiffs seek over $1 bln in Vioxx case 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?72353</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?72353</guid>
      <pubDate>2006-04-20 14:09:20</pubDate>
      	<description><![CDATA[    Reuters - Attorneys suing  Merck  &amp; 
Co. Inc.  for the death of a 71-year-old man who took 
Vioxx asked a Texas jury on Thursday to award more than &#36;1 
billion in damages, but  Merck  lawyers said the  pharmaceuticals  
company should not have to pay anything.  ]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136186.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[DrugMax announces preliminary Q1 results 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?65643</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?65643</guid>
      <pubDate>2006-04-10 09:02:17</pubDate>
      	<description><![CDATA[Reuters -  Pharmaceuticals  distributor DrugMax Inc. 
 reported preliminary results for the first quarter on 
Monday.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136179.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[FDA halts Cortex's sleep drug trial, shares plunge 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?60964</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?60964</guid>
      <pubDate>2006-04-03 10:33:32</pubDate>
      	<description><![CDATA[Reuters - Cortex  Pharmaceuticals  Inc.  shares lost 
almost half of their value in morning trade Monday after the 
U.S. Food and Drug Administration placed the clinical trial of 
the company's sleep disorder drug on hold.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136180.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[SGX forges leukemia cancer deal with Novartis 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?56849</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?56849</guid>
      <pubDate>2006-03-28 03:24:55</pubDate>
      	<description><![CDATA[Reuters - SGX  Pharmaceuticals  Inc.  late 
on Monday said Swiss drugmaker Novartis AG  had 
licensed its experimental drugs to treat leukemia and could 
eventually pay it more than $515 million under the deal.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136175.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[King may need new trial for Altace for kids 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?55021</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?55021</guid>
      <pubDate>2006-03-24 06:57:42</pubDate>
      	<description><![CDATA[Reuters - King  Pharmaceuticals , Inc.  on 
Friday said U.S. regulators have determined that clinical data 
on use by children of its Altace hypertension drug was 
insufficient and a new trial may be needed.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136174.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Shire sues Teva over generic Adderall XR plans 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?41185</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?41185</guid>
      <pubDate>2006-03-03 07:26:28</pubDate>
      	<description><![CDATA[Reuters - British drugmaker Shire Plc  said 
on Friday it was suing Teva  Pharmaceuticals   over the 
Israeli drugmaker's plans to make a cheap, copycat version of 
hyperactivity drug Adderall XR.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136173.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[King Pharma posts quarterly net loss 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?38894</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?38894</guid>
      <pubDate>2006-02-28 07:45:13</pubDate>
      	<description><![CDATA[Reuters - Drugmaker King  Pharmaceuticals  Inc. 
 on Tuesday posted a quarterly loss after taking a large 
charge tied to a research deal.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_136163.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
  </channel>
</rss>